Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Evidence-based care for breast cancer survivors: Communicating the Institute of Medicine Guidelines in medical practice
Patient Education and Counselling, 11/04/09
Royak–Schaler R et al. – Patients at greatest risk for breast cancer recurrence – those with less education, income, and resources – report limited guidance from their physicians about evidence–based, follow–up care guidelines, designed to minimize their risk. Physicians need strategies for effectively delivering the IOM Guidelines for Survivorship Care to disadvantaged breast cancer patients, to promote enhanced quality of life and reduced risk of recurrence.
Related Articles
The Posttraumatic Growth Inventory: an examination of the factor structure and invariance among breast cancer survivors
Psycho-Oncology, 11/10/09
Relevance Score: 80%
Breast, Colorectal and Prostate Cancer Screening for Cancer Survivors and Non-Cancer Patients in Community Practices
Journal of General Internal Medicine, 10/21/09
Relevance Score: 80%
Changes in and predictors of length of stay in hospital after surgery for breast cancer between 1997/98 and 2004/05 in two regions of England
BMC Health Services Research, 11/10/09
Relevance Score: 79%
Transitioning to Breast Cancer Survivorship: Perspectives of Patients, Cancer Specialists, and Primary Care Providers
Journal of General Internal Medicine, 10/23/09
Relevance Score: 79%
Experiences and concerns about returning to work for women breast cancer survivors: a literature review
Psycho-Oncology, 10/14/09
Relevance Score: 79%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
Breast Cancer Research and Treatment, 12/02/09
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
Breast Cancer Research and Treatment, 12/02/09
ETAR antagonist ZD4054 exhibits additive effects with aromatase inhibitors and fulvestrant in breast cancer therapy, and improves in vivo efficacy of anastrozole
Breast Cancer Research and Treatment, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


